BB&T Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $385K | Sell |
3,136
-20,724
| -87% | -$2.54M | ﹤0.01% | 1202 |
|
|
2019
Q2 | $3.36M | Sell |
23,860
-22,468
| -48% | -$3.16M | 0.03% | 459 |
|
|
2019
Q1 | $6.99M | Buy |
46,328
+26,532
| +134% | +$4M | 0.07% | 336 |
|
|
2018
Q4 | $2.46M | Sell |
19,796
-5,547
| -22% | -$689K | 0.03% | 496 |
|
|
2018
Q3 | $4.02M | Buy |
25,343
+19,912
| +367% | +$3.16M | 0.04% | 440 |
|
|
2018
Q2 | $760K | Sell |
5,431
-1,003
| -16% | -$140K | 0.01% | 904 |
|
|
2018
Q1 | $855K | Buy |
6,434
+4,544
| +240% | +$604K | 0.01% | 829 |
|
|
2017
Q4 | $235K | Sell |
1,890
-730
| -28% | -$90.8K | ﹤0.01% | 1270 |
|
|
2017
Q3 | $324K | Buy |
+2,620
| New | +$324K | ﹤0.01% | 1114 |
|
|
2017
Q1 | – | Sell |
-4,665
| Closed | -$465K | – | 1245 |
|
|
2016
Q4 | $465K | Hold |
4,665
| – | – | 0.01% | 853 |
|
|
2016
Q3 | $465K | Buy |
4,665
+22
| +0.5% | +$2.19K | 0.01% | 853 |
|
|
2016
Q2 | $415K | Buy |
4,643
+291
| +7% | +$26K | 0.01% | 853 |
|
|
2016
Q1 | $381K | Sell |
4,352
-30,872
| -88% | -$2.7M | 0.01% | 852 |
|
|
2015
Q4 | $3.98M | Buy |
35,224
+897
| +3% | +$101K | 0.08% | 230 |
|
|
2015
Q3 | $3.48M | Sell |
34,327
-14,423
| -30% | -$1.46M | 0.08% | 239 |
|
|
2015
Q2 | $6.05M | Sell |
48,750
-7,553
| -13% | -$937K | 0.13% | 160 |
|
|
2015
Q1 | $66.6M | Buy |
56,303
+1,011
| +2% | +$1.2M | 0.15% | 143 |
|
|
2014
Q4 | $56.4M | Sell |
55,292
-15,173
| -22% | -$15.5M | 0.13% | 156 |
|
|
2014
Q3 | $64.7M | Sell |
70,465
-24,171
| -26% | -$22.2M | 0.15% | 133 |
|
|
2014
Q2 | $77.9M | Buy |
94,636
+81,793
| +637% | +$67.3M | 0.19% | 111 |
|
|
2014
Q1 | $9.85M | Sell |
12,843
-2,490
| -16% | -$1.91M | 0.03% | 406 |
|
|
2013
Q4 | $10.6M | Sell |
15,333
-49
| -0.3% | -$33.9K | 0.03% | 365 |
|
|
2013
Q3 | $9.97M | Buy |
15,382
+8,473
| +123% | +$5.49M | 0.03% | 349 |
|
|
2013
Q2 | $4.02K | Buy |
+6,909
| New | +$4.02K | 0.01% | 543 |
|